Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 18 Neoplasms 14 Breast Neoplasms 13 Neuroendocrine Tumors 9 Lung Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Neoplasm Metastasis 6 Stomach Neoplasms 5 Esophageal Neoplasms 5 Uterine Cervical Neoplasms 4 Pancreatic Neoplasms 4 Multiple Myeloma 4 Disease 4 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Mouth Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Head and Neck Neoplasms 3 Glioma 3 Esophageal Squamous Cell Carcinoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplastic Cells, Circulating 2 Nasopharyngeal Carcinoma 2 Multiple Pulmonary Nodules 2 Lymphoma, Follicular 2 Lymphoma, B-Cell 2 Liver Neoplasms 2 Leukemia 2

Interventions

Cyclophosphamide 155 Dexamethasone 141 Rituximab 85 fludarabine 80 Lenalidomide 72 Cytarabine 70 Bortezomib 65 fludarabine phosphate 63 Gemcitabine 62 venetoclax 55 pomalidomide 53 Etoposide 53 pembrolizumab 52 Paclitaxel 48 Cisplatin 48 Carboplatin 48 Peripheral Blood Stem Cell Transplantation 47 Filgrastim 40 Radiotherapy 39 Busulfan 37 Calcium Dobesilate 36 Methotrexate 34 Melphalan 34 Bevacizumab 33 carfilzomib 32 Cyclosporine 32 Azacitidine 32 Mycophenolic Acid 30 Vincristine 29 Bendamustine Hydrochloride 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Positron Emission Tomography Computed Tomography × Clear all

NCT02181192 2016-08-01

PROST-I

University of Erlangen-Nürnberg Medical School

Phase NA Unknown

Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡